Sign up now with your company or organization email and enjoy a
1-week free trial!
Contract Details
| Title |
9/2022 - Design Service Spain |
|||
|---|---|---|---|---|
You can sign up and unlock it for freeAccess to Public and Private Sector Business Opportunities for 200+ Countries |
||||
| Country | ||||
| Language | English | |||
| Organization | ||||
| Published Date | 06.02.2024 | |||
| Awarded Date | 19.09.2022 | |||
| Overview | Contract Award's Details : 9/2022 - Design Service BARCELONA BIOMEDICAL RESEARCH PARK CONSORTIUM 2022-97 Supplies of the Advanced Therapy Drug with the Axicabtagén Ciloleleucel Active Infold 2022-97 Supplies of the advanced therapy drug with the Axicabtagén Ciloleucel Active Ingredient in the HCB with commercial denomination Yescarta Description of the provision: Supplies of the advanced therapy drug with the Axicabtagén Ciloleucel Active Ingredient in the 'HCB with commercial denomination Yescarta Lot description: estimated value of the contract: 9,888,480.00 € without VAT Data of the adjudicating company: denomination: Gilead Sciences, S.L. Nationality: Spain Amount: € 2,285,337.60 with VAT amount without VIV: € 2,197,440.00 Date of contract award: 09/19/22 Spain Contract value : 60,150.00 EUR Contractors : SALVADOR REGÀS AYMI 19/09/2022 20/09/2022 19/09/2023 78642957 21/09/2022 HOSPITAL CLÍNIC CONSORTIUM OF BARCELONA (HCB) Address : Spain Spain Spain Contract Awards Spain 19/09/2022 19/09/2023 9,888,480.00 EUR | |||
| NAICS | ||||
| CPVS | ||||
| UNSPSC |
-
|
|||
| Regions | ||||
| Sectors | ||||
| Contractor | ||||
| Contract Value |
9,888,480.00 EUR
|
URL | ||
| Share | ||||
Spain
| Title |
|---|
9/2022 - Design Service Spain |
| Country |
| Language |
| English |
| Organization |
| Published Date |
| 06.02.2024 |
| Awarded Date |
| 19.09.2022 |
| Overview |
| Contract Award's Details : 9/2022 - Design Service BARCELONA BIOMEDICAL RESEARCH PARK CONSORTIUM 2022-97 Supplies of the Advanced Therapy Drug with the Axicabtagén Ciloleleucel Active Infold 2022-97 Supplies of the advanced therapy drug with the Axicabtagén Ciloleucel Active Ingredient in the HCB with commercial denomination Yescarta Description of the provision: Supplies of the advanced therapy drug with the Axicabtagén Ciloleucel Active Ingredient in the 'HCB with commercial denomination Yescarta Lot description: estimated value of the contract: 9,888,480.00 € without VAT Data of the adjudicating company: denomination: Gilead Sciences, S.L. Nationality: Spain Amount: € 2,285,337.60 with VAT amount without VIV: € 2,197,440.00 Date of contract award: 09/19/22 Spain Contract value : 60,150.00 EUR Contractors : SALVADOR REGÀS AYMI 19/09/2022 20/09/2022 19/09/2023 78642957 21/09/2022 HOSPITAL CLÍNIC CONSORTIUM OF BARCELONA (HCB) Address : Spain Spain Spain Contract Awards Spain 19/09/2022 19/09/2023 9,888,480.00 EUR |
| NAICS |
| Automatic Environmental Control Manufacturing for Residential Commercial |
| CPVS |
| Research, testing and scientific technical simulator Vats Other services Designs Dates |
| UNSPSC |
| - |
| Regions |
| Europe Southern Europe Western Europe |
| Sectors |
| Automobiles and Auto Parts Supply Printing and Publishing Defence and Security Electricity Construction Energy-Power and Electrical Computer Hardwares and Consumables Aviation Marine |
| Contractor |
| Contract Value |
|
9,888,480.00 EUR
|
| URL |
|
|
| Share |
To be notified
when a tender matching your filter is
published
To Follow
Tenders
Add New Tender Alert
To Follow
Contracts
Add New Contract Alert
To Follow
Fairs
Add New Fair Alert
Similar Contracts